| Literature DB >> 31231753 |
Alyssa A Logan1, Brian D Nielsen1, Cara I Robison1, Jane M Manfredi2, Daniel D Buskirk1, Harold C Schott3, Kristina M Hiney4.
Abstract
Previous research has determined that maintaining young animals in stalls is detrimental to their bone health, while the addition of 50 to 82-m sprints 5 d/week aids in counteracting the reduction of bone strength from confinement. The current research aims to determine if 1 or 3 d/week of sprinting affords the same benefits to bone as 5 d/week of sprinting compared to animals confined with no sprinting. Twenty-four Holstein bull calves were obtained from the Michigan State University Dairy Cattle Teaching and Research Center. At 9 wk of age, calves were randomly assigned to treatments of 1, 3, or 5 d/week of sprint exercise, or to the confined control group sprinted 0 d/week. Each treatment had 6 calves. Individual sprinting bouts included a single sprint down a 71-m concrete aisle. For the duration of the 6-wk study, calves were housed at the MSU Beef Cattle Teaching and Research Center in stalls which afforded calves room to stand, lay down, and turn around. Serum was collected weekly via jugular venipuncture to obtain concentrations of osteocalcin (OC) and C-telopeptide crosslaps of type I collagen (CTX-1)-markers of bone formation and degradation, respectively. Sprints were videotaped weekly to determine stride frequency and sprint velocity. On day 42, calves were humanely euthanized at the Michigan State University Meat Lab and both front limbs were immediately harvested. Computed tomography scans and mechanical testing were performed on the left fused third and fourth metacarpal bones. Serum OC concentration was greatest for calves sprinted 5 d/week (P < 0.001). Calves sprinted 5 d/week had both greater stride frequency (P < 0.05) and lower sprint velocity (P < 0.05). All exercise treatments experienced greater dorsal cortical widths compared to control animals (P < 0.01). Through mechanical testing, fracture forces of all sprinting treatments were determined to be greater than the control treatment (P < 0.02). Results from this study support that sprinting 1, 3, or 5 d/week during growth can increase bone health and cause favorable alterations in bone markers. While all exercise treatments had over a 20% increase to fracture force, calves sprinted 1 d/week sprinted only 426 m over the 6-wk study and still experienced over a 20% increase in bone strength compared to confined calves. This study demonstrates the remarkably few strides at speed needed to enhance bone strength and emphasizes the danger to skeletal strength if sprinting opportunities are not afforded.Entities:
Keywords: bone; confinement; exercise; horse; juvenile; strength
Mesh:
Substances:
Year: 2019 PMID: 31231753 PMCID: PMC6667263 DOI: 10.1093/jas/skz202
Source DB: PubMed Journal: J Anim Sci ISSN: 0021-8812 Impact factor: 3.159
Treatment assignment of calves based on age-matched groups
| Group1 | Treatment2 0 d/week | Treatment 1 d/week | Treatment 3 d/week | Treatment 5 d/week | Total calves |
|---|---|---|---|---|---|
| 1 | 2 | 1 | 1 | 1 | 5 |
| 2 | 1 | 1 | 1 | 1 | 4 |
| 3 | 0 | 1 | 1 | 1 | 3 |
| 4 | 1 | 2 | 2 | 1 | 6 |
| 5 | 1 | 1 | 0 | 1 | 3 |
| 6 | 1 | 0 | 1 | 1 | 3 |
| Total calves | 6 | 6 | 6 | 6 | 24 |
1Calves assigned to a group had no more than a 10-d span between birthdates and groups had between 3 and 6 calves.
2Treatments are based on the number of sprints a calf performed per week: 0 sprints/wk, 1 sprint/wk, 3 sprints/wk, or 5 sprints/wk. A sprint was 71 m in length, and no calf performed more than 1 sprint in a day.
Figure 1.Graph used to calculate bone mineral density (BMD) of values obtained from computed tomography (CT) scans analyzed with Mimics. 1Values along the X-axis are average Hounsfield Units (HU) obtained from CT scans. 2Values along the Y-axis are known concentrations of rows in the hydroxyapatite phantom (0, 75, and 150 mg/cm3 Ca). The equation obtained from this regression outputs HU values as mg Ca hydroxyapatite/cm3.
Figure 2.Diagram of a bovine fused third and fourth metacarpal subjected to 4-point bending on an Instron. Load exerted (F) on the bone is shown, as the Instron measures the bone’s displacement (V). Measurements: L is span length, set at 100 mm; a is the distance between F, and the support on either end of the bone, this was measured individually for each calf and averaged 38.6 mm. Adapted from Pruyn et al. (2000).
Figure 3.Cross-section of bovine fused third and fourth metacarpal illustration. Cortical diameters included: B = exterior lateromedial diameter, b = interior lateromedial diameter, D = exterior dorsopalmar diameter, d = interior dorsopalmar diameter. Adapted from Hiney et al. (2004a).
Calf size parameters measured at the beginning and end of the study
| Treatment | Calf age at day 0 | Initial1 height, cm | Final2 height, cm | Initial weight, kg | Final weight, kg | Initial length, cm | Final length, cm | ADG3, kg/d |
|---|---|---|---|---|---|---|---|---|
| 0 | 62 ± 1 | 90 ± 1 | 100 ± 1 | 89 ± 3 | 115 ± 7 | 67 ± 1 | 75 ± 2 | 0.6 ± 0.2 |
| 1 | 62 ± 1 | 92 ± 1 | 101 ± 1 | 85 ± 3 | 117 ± 7 | 67 ± 1 | 75 ± 2 | 0.8 ± 0.2 |
| 3 | 63 ± 1 | 93 ± 1 | 101 ± 1 | 85 ± 3 | 119 ± 7 | 68 ± 1 | 74 ± 2 | 0.8 ± 0.2 |
| 5 | 63 ± 1 | 91 ± 1 | 101 ± 1 | 79 ± 3 | 116 ± 7 | 65 ± 1 | 75 ± 2 | 0.9 ± 0.2 |
|
| 0.99 | 0.49 | 0.90 | 0.16 | 0.97 | 0.49 | 0.99 | 0.60 |
1All initial measurements were taken on day −1.
2All final measurements were taken on day 41.
3ADG = Average daily gain =
Inverse mean calf stride frequency and velocity by sprinting treatment over the 6-wk study period
| Inverse stride frequency, 1·strides-1·sprint-1 | Velocity, m/s | ||||||
|---|---|---|---|---|---|---|---|
| Treatment | 1 d/weeka | 3 d/weeka | 5 d/weekb | Treatment | 1 d/weeka | 3 d/weeka | 5 d/weekb |
|
| 0.07 | 0.05 | 0.07 | Week 1a | 2.8 | 2.1 | 2.9 |
|
| 0.07 | 0.08 | 0.05 | Week 2ab | 3.1 | 3.6 | 1.9 |
|
| 0.09 | 0.10 | 0.08 | Week 3bc | 3.8 | 4.1 | 4.1 |
|
| 0.12 | 0.10 | 0.08 | Week 4c | 5.4 | 5.2 | 3.0 |
|
| 0.10 | 0.10 | 0.06 | Week 5c | 5.4 | 5.0 | 2.5 |
|
| 0.07 | 0.09 | 0.08 | Week 6abc | 3.1 | 4.0 | 3.6 |
| SEM | 0.01 | 0.01 | 0.01 | SEM | 1 | 1 | 1 |
a–cWithin a row or column, main effect means differ (P < 0.05).
Figure 4.Mean calf serum osteocalcin concentration by treatment throughout the 6-wk study period. 1Difference among weeks not significant (P = 0.11). 2Interaction between treatment and week not significant (P = 0.99). a,bTreatments lacking common superscripts in legend differ (
Figure 5.Mean C-terminal telopeptides of type 1 collagen (CTX-1) concentration in calf serum by treatment throughout the 6-wk study period. 1Difference among treatments not significant (P = 0.16). 2Difference among weeks not significant (P = 0.32). 3Interaction between treatment and week not significant (P = 0.94).
Internal (Int) and external (Ext) dorsopalmar (DP) and mediolateral (ML) diameters from cross-sectional views at midpoints calculated from the proximal end of the fused third and fourth metacarpal to the distal end (MID)
| Treatment | MID ML Int, mm | MID ML Ext, mm | MID DP Int, mm | MID DP Ext, mm |
|---|---|---|---|---|
| 0 | 17.4x | 26.8 | 11.9 | 20.3 |
| 1 | 18.9y | 28.2 | 11.6 | 20.5 |
| 3 | 17.0x | 27.3 | 11.0 | 20.7 |
| 5 | 17.3x | 27.3 | 11.2 | 20.3 |
| SEM | 0.5 | 0.7 | 0.5 | 0.4 |
|
| 0.06 | 0.48 | 0.53 | 0.89 |
x,yValues lacking common superscripts tend to differ (P < 0.10).
Cross-sectional cortical widths (CW), cross-sectional cortical areas, and cortical areas measured at midpoints calculated from the proximal end of the fused third and fourth metacarpal to the distal end (MID)
| Treatment | Dorsal CW, mm | Palmar CW, mm | Lateral CW, mm | Medial CW, mm | MID cross-sectional area, mm2 | MID cortical area, mm2 |
|---|---|---|---|---|---|---|
| 0 | 4.3a | 4.1 | 4.5 | 4.9 | 437 | 288 |
| 1 | 4.9b | 3.9 | 4.9 | 4.7 | 465 | 309 |
| 3 | 5.5b | 4.2 | 4.9 | 5.3 | 451 | 320 |
| 5 | 4.9b | 4.1 | 5.0 | 5.1 | 453 | 318 |
| SEM | 0.2 | 0.2 | 0.2 | 0.2 | 20 | 15 |
|
| 0.006 | 0.67 | 0.16 | 0.24 | 0.80 | 0.43 |
a,bValues lacking common superscripts differ (P < 0.01).
Cortical and whole-slice bone densities from a cross-sectional view at a midpoint calculated from the proximal end of the fused third and fourth metacarpal and the distal end (MID)
| Treatment | Whole-slice, mg mineral/cm3 | Dorsal, mg mineral/cm3 | Lateral, mg mineral/cm3 | Medial, mg mineral/cm3 | Palmar, mg mineral/cm3 |
|---|---|---|---|---|---|
| 0 | 996 | 1,210 | 1,220 | 1,230 | 1,060 |
| 1 | 997 | 1,130 | 1,250 | 1,240 | 1,040 |
| 3 | 987 | 1,210 | 1,220 | 1,210 | 1,070 |
| 5 | 982 | 1,220 | 1,220 | 1,210 | 1,050 |
| SEM | 13 | 28 | 20 | 17 | 18 |
|
| 0.82 | 0.13 | 0.57 | 0.55 | 0.78 |
Fracture force and calculated mechanical properties of the fused third and fourth metacarpal of calves separated by treatments
| Treatment | Moment of inertia, mm4 | Flexural rigidity, × 107 Nmm2 | Young’s modulus, N·mm-2 | Fracture force, |
|---|---|---|---|---|
| 0 | 9,660 | 2.3 | 2,530 | 6,300a |
| 1 | 10,400 | 2.6 | 2,490 | 7,940b |
| 3 | 10,800 | 2.4 | 2,210 | 7,850b |
| 5 | 10,200 | 3.0 | 3,220 | 7,550b |
| SEM | 813 | 0.5 | 543 | 358 |
|
| 0.81 | 0.78 | 0.61 | 0.01 |
a,bValues lacking common superscripts differ (P = 0.01).